Literature DB >> 31043546

Effect of Osteoarthritis on Work Participation and Loss of Working Life-years.

Tea Kontio1,2, Eira Viikari-Juntura1,2, Svetlana Solovieva3,4.   

Abstract

OBJECTIVE: To examine to what extent disabling osteoarthritis (OA), leading to a prolonged sickness absence (SA), interferes with work participation and shortens working life-years.
METHODS: A total of 4704 wage earners aged 30 to 59 years, whose SA due to OA started in 2006, were followed until October 31, 2014. Kaplan-Meier analysis was used to plot sustained (at least 28 consecutive days) return-to-work curves. The associations of potential determinants with early exit from paid employment were examined applying Cox proportional hazards regression analysis. Years expected to be spent in different work participation statuses until statutory retirement age were estimated based on daily work participation statuses using adapted Sullivan method.
RESULTS: Persons with knee OA showed the fastest, and persons with hip OA the slowest, sustained return to work. Although most participants typically were at work during the first year of followup, a considerable proportion was permanently retired. Male sex, older age, low education, long initial SA, and having not returned to work sustainably, as well as receiving vocational rehabilitation, predicted early exit from paid employment during the followup. Overall, only 45-53% of potential working life-years were estimated to be spent at work, being highest for the oldest age group.
CONCLUSION: Our study showed a considerable effect of OA on work participation and working life duration. Clinicians should avoid prescription of long SA or temporary work disability due to OA without a clear treatment or return-to-work plan.

Entities:  

Keywords:  EMPLOYMENT; OSTEOARTHRITIS; REHABILITATION; RETIREMENT; RETURN TO WORK; VOCATIONAL

Year:  2019        PMID: 31043546     DOI: 10.3899/jrheum.181284

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Has the share of the working life expectancy that is spent receiving a partial or full disability pension changed in Finland over the period 2005-2018? A longitudinal register-based study.

Authors:  Taina Leinonen; Eira Viikari-Juntura; Svetlana Solovieva
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

2.  Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis.

Authors:  Xiaojian Huang; Bowei Ni; Yang Xi; Xiangyu Chu; Rui Zhang; Hongbo You
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

3.  Sickness absence and return to work among employees with knee osteoarthritis with and without total knee arthroplasty: a prospective register linkage study among Finnish public sector employees.

Authors:  Leena Kaila-Kangas; Päivi Leino-Arjas; Aki Koskinen; Esa-Pekka Takala; Tuula Oksanen; Jenni Ervasti; Johanna Kausto
Journal:  Scand J Work Environ Health       Date:  2021-09-26       Impact factor: 5.492

4.  Overexpression of miR-10a-5p facilitates the progression of osteoarthritis.

Authors:  Hui-Zi Li; Xiang-He Xu; Nan Lin; Da-Wei Wang; Yi-Ming Lin; Zhong-Zhen Su; Hua-Ding Lu
Journal:  Aging (Albany NY)       Date:  2020-04-13       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.